World Vaccine Congress Brochure Available

  The World Vaccine Congress Washington is now in its 15th year, and things look a little different to previous years. ‘So why the change?’ I hear you ask… In my previous role, we produced very focused agendas and ran two-day events specifically on that area. This would be as niche as talking only about foundations for deep water offshore …

Top 4 Challenges for Vaccine Manufacturers

Recently we undertook the research for the 15th annual World Vaccine Congress, and so asked what the biggest challenges are for each segment of the market. When we spoke to vaccine manufacturers, these came up as the 4 biggest issues:   1)      Adjuvants Adjuvants are often lauded as the way forward to make vaccines more effective, but given how new …

MaxCyte

MaxCyte Introduces Rapid, Automated, Scalable Flow Electroporation-based Technology for Vaccine Development

Data on the use of MaxCyte electroporation to transfect insect cells without baculovirus to be presented. March 20, 2014 MaxCyte®, Inc., the pioneer in scalable, high-performance cell transfection systems, will present data in both a scientific talk and a poster during the World Vaccine Congress on March 24-26, 2014, that demonstrates the use of flow electroporation for the rapid and …

Synco BioPartners at the World Vaccine Congress and Expo 2013

After a successful trip to the World Vaccine Congress 2013, Scynco BioPartners, a contract manufacturing organisation (SMO) based in Amsterdam and focused entirely on biologics,  will be joining us at this years World Vaccine Congress and Expo Washington, March 24-26 2014. The World Vaccine Congress and Expo 2014 is just around the corner. It will see industry leaders from across …

White Paper: Scaling-up Influenza: Improving manufacturing agility with GE Healthcare

Overview of a scale-up of a cell-based influenza virus production process using ReadyToProcess equipment posted on behalf of GE Healthcare Life Sciences “The aim of this white paper is to demonstrate how GE Healthcare Life Sciences single-use products can be applied in the field of vaccine manufacturing. The white paper includes a brief discussion around modern vaccine processes, followed by a …

Pricing of new #vaccines

Dr Bruce Lee, Associate Professor of Medicine, Epidemiology, and Biomedical Informatics at the University of Pittsburgh delivered a presentation at this year's World Vaccine Congress Washington about Impact of pricing strategies on new vaccine adoption and R&D.   Dr. Lee, who previously ran a modelling group for Quintiles, discussed the pricing of new vaccines in the context of eleven steps …